| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30034199 | HIV | ENSG00000135090.14 | protein_coding | TAOK3 | No | No | 51347 | G3V1Q8 Q9H2K8 |
| TVIS30034200 | HIV | ENSG00000135090.14 | protein_coding | TAOK3 | No | No | 51347 | G3V1Q8 Q9H2K8 |
| TVIS30034201 | HIV | ENSG00000135090.14 | protein_coding | TAOK3 | No | No | 51347 | G3V1Q8 Q9H2K8 |
| TVIS30034202 | HIV | ENSG00000135090.14 | protein_coding | TAOK3 | No | No | 51347 | G3V1Q8 Q9H2K8 |
| TVIS30034203 | HIV | ENSG00000135090.14 | protein_coding | TAOK3 | No | No | 51347 | G3V1Q8 Q9H2K8 |
| TVIS30034204 | HIV | ENSG00000135090.14 | protein_coding | TAOK3 | No | No | 51347 | G3V1Q8 Q9H2K8 |
| TVIS30034205 | HIV | ENSG00000135090.14 | protein_coding | TAOK3 | No | No | 51347 | G3V1Q8 Q9H2K8 |
| TVIS30034206 | HIV | ENSG00000135090.14 | protein_coding | TAOK3 | No | No | 51347 | G3V1Q8 Q9H2K8 |
| TVIS30034207 | HIV | ENSG00000135090.14 | protein_coding | TAOK3 | No | No | 51347 | G3V1Q8 Q9H2K8 |
| TVIS30034208 | HIV | ENSG00000135090.14 | protein_coding | TAOK3 | No | No | 51347 | G3V1Q8 Q9H2K8 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | TAOK3 |
|---|---|
| DrugBank ID | DB12010 |
| Drug Name | Fostamatinib |
| Target ID | BE0009393 |
| UniProt ID | Q9H2K8 |
| Regulation Type | inhibitor |
| PubMed IDs | 26516587 |
| Citations | Rolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4. |
| Groups | Approved; Investigational |
| Direct Classification | Methoxyanilines |
| SMILES | COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL2103830 |
